ČULEN, Martin, Tomáš LOJA, Daniel BUŠA, Zdeňka HERUDKOVÁ, Jan HÝL, Jakub VLAŽNÝ, K. LIŠKOVÁ, Martin REPKO, Lucy VOJTOVÁ and Jiří MAYER. Biomaterial selection does not affect AML engraftment in humanized ossicles. (Biomaterial selection does not affect AML engraftment in humanized ossicles - conference abstract.). In 12th International Conference Analytical Cytometry, Praha. 2023.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Biomaterial selection does not affect AML engraftment in humanized ossicles.
Authors ČULEN, Martin (703 Slovakia, belonging to the institution), Tomáš LOJA (703 Slovakia, belonging to the institution), Daniel BUŠA (703 Slovakia, belonging to the institution), Zdeňka HERUDKOVÁ (203 Czech Republic, belonging to the institution), Jan HÝL (203 Czech Republic, belonging to the institution), Jakub VLAŽNÝ (203 Czech Republic, belonging to the institution), K. LIŠKOVÁ (203 Czech Republic), Martin REPKO (203 Czech Republic, belonging to the institution), Lucy VOJTOVÁ (203 Czech Republic) and Jiří MAYER (203 Czech Republic, belonging to the institution).
Edition 12th International Conference Analytical Cytometry, Praha, 2023.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30205 Hematology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/23:00131652
Organization unit Faculty of Medicine
Keywords in English AML; humanized ossicles
Tags rivok
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 13/3/2024 09:42.
Abstract
Biomaterial selection does not affect AML engraftment in humanized ossicles - conference abstract.
Links
LX22NPO5102, research and development projectName: Národní ústav pro výzkum rakoviny (Acronym: NÚVR)
Investor: Ministry of Education, Youth and Sports of the CR, National institute for cancer research, 5.1 EXCELES
MUNI/A/1224/2022, interní kód MUName: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit X
Investor: Masaryk University
PrintDisplayed: 8/7/2024 08:39